DaVita, Inc. (NYSE:DVA)

CAPS Rating: 3 out of 5

The Company is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease.

Recs

0
Player Avatar konazo (67.78) Submitted: 10/15/2006 5:32:31 PM : Outperform Start Price: $56.40 DVA Score: +42.25

good

Report this Post Reply

Featured Broker Partners


Advertisement